Molecular Alterations in Malignant Pleural Mesothelioma: A Hope for Effective Treatment by Targeting YAP.
Journal
Targeted oncology
ISSN: 1776-260X
Titre abrégé: Target Oncol
Pays: France
ID NLM: 101270595
Informations de publication
Date de publication:
07 2022
07 2022
Historique:
accepted:
05
07
2022
pubmed:
30
7
2022
medline:
5
8
2022
entrez:
29
7
2022
Statut:
ppublish
Résumé
Malignant pleural mesothelioma is a rare and aggressive neoplasm, which has primarily been attributed to the exposure to asbestos fibers (83% of cases); yet, despite a ban of using asbestos in many countries, the incidence of malignant pleural mesothelioma failed to decline worldwide. While little progress has been made in malignant pleural mesothelioma diagnosis, bevacizumab at first, then followed by double immunotherapy (nivolumab plus ipilumumab), were all shown to improve survival in large phase III randomized trials. The morphological analysis of the histological subtyping remains the primary indicator for therapeutic decision making at an advanced disease stage, while a platinum-based chemotherapy regimen combined with pemetrexed, either with or without bevacizumab, is still the main treatment option. Consequently, malignant pleural mesothelioma still represents a significant health concern owing to poor median survival (12-18 months). Given this context, both diagnosis and therapy improvements require better knowledge of the molecular mechanisms underlying malignant pleural mesothelioma's carcinogenesis and progression. Hence, the Hippo pathway in malignant pleural mesothelioma initiation and progression has recently received increasing attention, as the aberrant expression of its core components may be closely related to patient prognosis. The purpose of this review was to provide a critical analysis of our current knowledge on these topics, the main focus being on the available evidence concerning the role of each Hippo pathway's member as a promising biomarker, enabling detection of the disease at earlier stages and thus improving prognosis.
Identifiants
pubmed: 35906513
doi: 10.1007/s11523-022-00900-2
pii: 10.1007/s11523-022-00900-2
pmc: PMC9345804
doi:
Substances chimiques
Pemetrexed
04Q9AIZ7NO
Asbestos
1332-21-4
Bevacizumab
2S9ZZM9Q9V
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
407-431Informations de copyright
© 2022. The Author(s).
Références
Occup Environ Med. 2016 May;73(5):290-9
pubmed: 26715106
Mol Cancer Res. 2015 May;13(5):879-90
pubmed: 25652588
EMBO J. 2013 Mar 20;32(6):874-85
pubmed: 23435566
Occup Environ Med. 2015 Mar;72(3):216-8
pubmed: 25231672
Genes Dev. 2020 Apr 1;34(7-8):511-525
pubmed: 32115406
Carcinogenesis. 2007 Jul;28(7):1599-605
pubmed: 17272307
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1785-90
pubmed: 25624491
J Cell Biol. 2004 Mar 29;164(7):1009-20
pubmed: 15037601
Anticancer Res. 2012 Mar;32(3):1005-13
pubmed: 22399624
Nature. 2015 Mar 5;519(7541):57-62
pubmed: 25731159
Ann Diagn Pathol. 2016 Aug;23:1-7
pubmed: 27402216
Nat Med. 2015 Nov;21(11):1344-9
pubmed: 26437366
Oncotarget. 2017 Jan 10;8(2):2171-2186
pubmed: 27974689
EMBO Rep. 2015 Aug;16(8):975-85
pubmed: 26116754
Oncotarget. 2015 Jul 10;6(19):16848-65
pubmed: 26078352
J Invest Dermatol. 2014 Jan;134(1):123-132
pubmed: 23897276
Lancet. 2021 Jan 30;397(10272):375-386
pubmed: 33485464
J Biol Chem. 2004 May 28;279(22):23806-12
pubmed: 15037617
Cancers (Basel). 2021 Aug 20;13(16):
pubmed: 34439349
Cancer Chemother Pharmacol. 2017 Oct;80(4):861-867
pubmed: 28756516
Cell Res. 2014 Mar;24(3):331-43
pubmed: 24458094
Front Cell Dev Biol. 2021 Apr 01;9:658481
pubmed: 33869224
Oncogene. 2005 Mar 17;24(12):2076-86
pubmed: 15688006
Respir Investig. 2013 Jun;51(2):92-7
pubmed: 23790737
Cancer. 2007 Apr 15;109(8):1454-61
pubmed: 17348013
J Thorac Oncol. 2011 May;6(5):864-74
pubmed: 21774103
Genes Chromosomes Cancer. 2018 Nov;57(11):573-583
pubmed: 30338612
Ann Transl Med. 2017 Jun;5(11):238
pubmed: 28706906
Cancer Res. 2016 Apr 1;76(7):1847-59
pubmed: 26825171
J Thorac Oncol. 2015 May;10(5):844-851
pubmed: 25902174
Lancet. 2016 Apr 2;387(10026):1405-1414
pubmed: 26719230
Genes Chromosomes Cancer. 2015 Jan;54(1):51-62
pubmed: 25231345
Cancer Causes Control. 2013 Aug;24(8):1535-45
pubmed: 23702885
Transl Lung Cancer Res. 2014 Apr;3(2):75-83
pubmed: 25806284
Cell Commun Signal. 2018 Oct 11;16(1):66
pubmed: 30305100
Cancer Res. 2016 Jan 15;76(2):206-15
pubmed: 26719535
Cancers (Basel). 2020 May 07;12(5):
pubmed: 32392897
Clin Cancer Res. 2017 Jun 15;23(12):3191-3202
pubmed: 28003305
Biochem Biophys Res Commun. 2006 Apr 21;342(4):1228-32
pubmed: 16516163
Biochem Pharmacol. 2017 Jan 1;123:8-18
pubmed: 27431778
Mol Cell Biol. 2010 Sep;30(18):4507-20
pubmed: 20624913
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
Int J Mol Med. 2009 Mar;23(3):357-62
pubmed: 19212654
Oncotarget. 2017 Aug 3;8(42):72513-72527
pubmed: 29069806
Trends Cell Biol. 2020 Jan;30(1):32-48
pubmed: 31806419
Br J Cancer. 2020 Jan;122(1):52-61
pubmed: 31819191
Clin Lung Cancer. 2019 Sep;20(5):e564-e575
pubmed: 31279641
Nat Rev Mol Cell Biol. 2010 Jan;11(1):9-22
pubmed: 20027184
Clin Cancer Res. 2012 Sep 1;18(17):4485-90
pubmed: 22825583
Cancer Res. 1994 Aug 15;54(16):4516-23
pubmed: 7519123
J Thorac Oncol. 2018 Oct;13(10):1588-1594
pubmed: 30056163
Nat Rev Cancer. 2017 Jul 25;17(8):475-488
pubmed: 28740119
Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25543-25552
pubmed: 32999071
Dev Cell. 2012 Apr 17;22(4):695-702
pubmed: 22516196
Genes Dev. 2013 Feb 15;27(4):355-71
pubmed: 23431053
Oncogene. 2016 Feb 4;35(5):537-48
pubmed: 25893302
Ther Adv Med Oncol. 2020 Nov 12;12:1758835920971421
pubmed: 33240401
J Physiol Pharmacol. 2017 Jun;68(3):311-335
pubmed: 28820389
Cancer Res. 2010 Mar 15;70(6):2455-64
pubmed: 20197461
J Clin Oncol. 2007 Apr 20;25(12):1489-97
pubmed: 17372278
Curr Biol. 2015 Oct 5;25(19):2479-92
pubmed: 26387716
BMC Cancer. 2019 May 28;19(1):507
pubmed: 31138176
Genes Cells. 2015 Oct;20(10):847-59
pubmed: 26289026
Exp Biol Med (Maywood). 2013 Mar;238(3):324-38
pubmed: 23598979
Clin Cancer Res. 2021 Apr 15;27(8):2277-2291
pubmed: 33547197
Sci Transl Med. 2014 May 21;6(237):237ra68
pubmed: 24848258
Cancer. 1994 Mar 1;73(5):1406-10
pubmed: 8111707
Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188437
pubmed: 32976979
J Cell Mol Med. 2017 Nov;21(11):2663-2676
pubmed: 28470935
Semin Cell Dev Biol. 2012 Sep;23(7):770-84
pubmed: 22898666
J Thorac Oncol. 2018 Sep;13(9):1269-1283
pubmed: 29966799
Int J Mol Sci. 2020 Jul 21;21(14):
pubmed: 32708306
Int J Oncol. 2015 Apr;46(4):1444-52
pubmed: 25652178
Sci Rep. 2016 Jun 23;6:28488
pubmed: 27335147
Cell Res. 2015 Jul;25(7):801-17
pubmed: 26045165
J Cell Biol. 2015 Sep 14;210(6):871-82
pubmed: 26370497
J Biomed Biotechnol. 2012;2012:492608
pubmed: 22500091
J Clin Oncol. 2019 Apr 1;37(10):790-798
pubmed: 30785827
Expert Opin Drug Deliv. 2019 Apr;16(4):441-451
pubmed: 30916586
Acta Biochim Biophys Sin (Shanghai). 2015 Jan;47(1):16-28
pubmed: 25487920
Front Cell Dev Biol. 2020 Mar 19;8:161
pubmed: 32266255
Am J Surg Pathol. 2018 Feb;42(2):256-263
pubmed: 29076876
Nat Rev Drug Discov. 2014 Jan;13(1):63-79
pubmed: 24336504
J Pathol. 1999 Sep;189(1):72-8
pubmed: 10451491
J Biol Chem. 2008 Feb 29;283(9):5496-509
pubmed: 18158288
Respir Res. 2017 Apr 12;18(1):58
pubmed: 28403901
EBioMedicine. 2016 Jun;8:30-39
pubmed: 27428416
Clin Cancer Res. 2009 Dec 15;15(24):7462-7468
pubmed: 20008845
Cell Commun Signal. 2020 Apr 16;18(1):63
pubmed: 32299434
J Exp Clin Cancer Res. 2019 Aug 9;38(1):349
pubmed: 31399037
Trends Cancer. 2019 Nov;5(11):662-665
pubmed: 31735284
Cell Death Dis. 2019 Dec 5;10(12):928
pubmed: 31804463
Genes Dev. 2012 Sep 1;26(17):1959-71
pubmed: 22948661
Curr Biol. 2009 Apr 28;19(8):675-81
pubmed: 19327996
Curr Biol. 2008 Dec 9;18(23):1889-95
pubmed: 19062280
Nature. 2011 Jun 08;474(7350):179-83
pubmed: 21654799
Cancer Res. 2006 Jan 1;66(1):352-61
pubmed: 16397249
Cell Biosci. 2013 Aug 28;3(1):33
pubmed: 23985334
Int J Mol Sci. 2014 May 28;15(6):9519-30
pubmed: 24879524
Cell Cycle. 2009 Jan 1;8(1):49-57
pubmed: 19106601
Lung Cancer. 2018 Oct;124:12-18
pubmed: 30268449
J Hematol Oncol. 2018 May 10;11(1):64
pubmed: 29747682
Occup Med (Lond). 2015 Jan;65(1):6-14
pubmed: 25559791
Oncogene. 2012 Jan 5;31(1):128-34
pubmed: 21685940
Cancers (Basel). 2021 Feb 06;13(4):
pubmed: 33562138
J Biol Chem. 2008 Jun 20;283(25):17635-51
pubmed: 18441325
J Thorac Dis. 2019 Apr;11(4):1456-1464
pubmed: 31179088
J Cell Biol. 2015 Aug 3;210(3):503-15
pubmed: 26216901
Bioessays. 2020 May;42(5):e1900162
pubmed: 32128850
Ann Oncol. 2018 May 1;29(5):1258-1265
pubmed: 29514216
EMBO J. 1998 Apr 15;17(8):2224-34
pubmed: 9545236
J Biol Chem. 2011 Mar 11;286(10):7788-7796
pubmed: 21233212
Mol Oncol. 2019 Jun;13(6):1335-1341
pubmed: 31050214
J Cell Sci. 2007 Sep 15;120(Pt 18):3163-72
pubmed: 17878233
J Thorac Oncol. 2012 Mar;7(3):599-606
pubmed: 22246193
Nat Commun. 2021 Aug 13;12(1):4920
pubmed: 34389715
Genes Dev. 2016 Apr 1;30(7):798-811
pubmed: 27013234
Lung Cancer. 2009 May;64(2):140-7
pubmed: 18835652
J Biol Chem. 2008 Oct 10;283(41):27534-27546
pubmed: 18640976
J Invest Dermatol. 2009 Jun;129(6):1321-4
pubmed: 19434087
Nagoya J Med Sci. 2009 Feb;71(1-2):1-10
pubmed: 19358470
Lung Cancer. 2006 Feb;51(2):207-15
pubmed: 16384623
Nat Genet. 2016 Apr;48(4):407-16
pubmed: 26928227
Cancer Metastasis Rev. 2014 Mar;33(1):173-81
pubmed: 24346160
Ann Transl Med. 2017 Dec;5(24):497
pubmed: 29299458
Curr Biol. 2008 Mar 11;18(5):311-21
pubmed: 18328708
J Cell Signal. 2016 Sep 6;1:125
pubmed: 28239681
Gene. 2012 Nov 10;509(2):215-22
pubmed: 22939869
Cancer Res. 2005 May 1;65(9):3497-508
pubmed: 15867337
PLoS One. 2015 Dec 14;10(12):e0145039
pubmed: 26660351
J Hepatol. 2014 Nov;61(5):1088-96
pubmed: 25010260
Cell Cycle. 2011 Jun 15;10(12):1897-904
pubmed: 21593588
Nat Genet. 2011 Aug 28;43(10):1022-5
pubmed: 21874000
Br J Cancer. 2019 Feb;120(4):387-397
pubmed: 30739911
Transl Lung Cancer Res. 2018 Oct;7(5):537-542
pubmed: 30450291
Semin Cancer Biol. 2018 Feb;48:104-114
pubmed: 28579171
Front Immunol. 2020 Mar 24;11:534
pubmed: 32265942
Cell. 2012 Dec 21;151(7):1457-73
pubmed: 23245941
Cancers (Basel). 2021 Mar 29;13(7):
pubmed: 33805359
Br J Cancer. 1999 Sep;81(1):54-61
pubmed: 10487612
J Histochem Cytochem. 2007 Dec;55(12):1191-8
pubmed: 17827165
Exp Cell Res. 2010 May 1;316(8):1324-31
pubmed: 20211171
Cell Death Dis. 2017 Jan 12;8(1):e2546
pubmed: 28079891
Nat Immunol. 2019 Jan;20(1):1
pubmed: 30538332
Nat Cell Biol. 2012 Aug;14(8):793-801
pubmed: 22797597
Lancet Oncol. 2019 Feb;20(2):239-253
pubmed: 30660609
Radiol Oncol. 2019 Mar 14;53(2):206-212
pubmed: 30893058
Cancers (Basel). 2020 May 26;12(6):
pubmed: 32466572
Genes Dev. 2015 Jul 1;29(13):1416-31
pubmed: 26108669
Front Oncol. 2020 Dec 14;10:554570
pubmed: 33381446
Cancer Res. 2016 Jan 15;76(2):319-28
pubmed: 26554828
Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):118-25
pubmed: 25679064
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10397-10402
pubmed: 16798876
Cell Biosci. 2013 Aug 28;3(1):32
pubmed: 23985307
Front Immunol. 2015 May 06;6:201
pubmed: 25999946
Lung Cancer. 2014 Oct;86(1):35-40
pubmed: 25174276
Int J Environ Res Public Health. 2018 Mar 16;15(3):
pubmed: 29547510
Biochem Biophys Res Commun. 2013 Oct 11;440(1):82-7
pubmed: 24041698
Genes Dev. 2007 Nov 1;21(21):2747-61
pubmed: 17974916
Mol Oncol. 2020 Jun;14(6):1207-1223
pubmed: 32083805
J Cell Biochem. 2012 Jul;113(7):2234-47
pubmed: 22573546
J Toxicol Environ Health B Crit Rev. 2011;14(1-4):179-245
pubmed: 21534089
Lung Cancer. 2006 Oct;54(1):109-16
pubmed: 16893590
Front Immunol. 2015 Apr 08;6:154
pubmed: 25904917
Mol Cancer Ther. 2017 Aug;16(8):1693-1704
pubmed: 28468780
Physiol Rev. 2014 Oct;94(4):1287-312
pubmed: 25287865
Sci Rep. 2019 Mar 18;9(1):4771
pubmed: 30886324
Cell. 2011 Mar 4;144(5):782-95
pubmed: 21376238
Stem Cells Int. 2017;2017:6917941
pubmed: 28659978
Genes Dev. 2002 Dec 1;16(23):3074-86
pubmed: 12464636
Lung Cancer. 2008 Mar;59(3):369-76
pubmed: 17920725
J Cell Sci. 2016 Dec 15;129(24):4466-4479
pubmed: 27807006
Eur Respir J. 1996 Sep;9(9):1932-42
pubmed: 8880114
Front Oncol. 2015 Sep 02;5:190
pubmed: 26389076
Nat Cell Biol. 2014 Apr;16(4):357-66
pubmed: 24658687
Oncogene. 2018 Dec;37(49):6357-6367
pubmed: 30061637
Br J Cancer. 2013 Apr 30;108(8):1743-9
pubmed: 23558893
Mol Biol Evol. 2011 Aug;28(8):2403-17
pubmed: 21415026
Adv Cancer Res. 1997;71:241-319
pubmed: 9111868
Mol Oncol. 2016 Oct;10(8):1255-65
pubmed: 27378628
Cell Death Differ. 2017 Sep;24(9):1488-1501
pubmed: 28644436
Curr Biol. 2017 Nov 6;27(21):3302-3314.e6
pubmed: 29112861
Clin Transl Med. 2014 Jul 10;3:22
pubmed: 25097725
Carcinogenesis. 2013 Jul;34(7):1413-9
pubmed: 23677068
Genes (Basel). 2018 Mar 13;9(3):
pubmed: 29534050
Nat Commun. 2016 Jul 13;7:12133
pubmed: 27405641
Adv Cancer Res. 2014;123:255-75
pubmed: 25081533
Cancer Immunol Immunother. 2010 Oct;59(10):1543-9
pubmed: 20567822
Bull Cancer. 2013 Dec;100(12):1283-93
pubmed: 24225007
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2021 Feb 20;39(2):91-98
pubmed: 33691361
Biochem Soc Trans. 2012 Feb;40(1):124-8
pubmed: 22260677
Dev Cell. 2010 Feb 16;18(2):288-99
pubmed: 20159598
Proc Natl Acad Sci U S A. 1995 Nov 21;92(24):10854-8
pubmed: 7479897
Cancer Res. 2015 Jan 15;75(2):264-9
pubmed: 25488749
Trends Cancer. 2019 May;5(5):297-307
pubmed: 31174842
Nat Genet. 2011 Jun 05;43(7):668-72
pubmed: 21642991
J Clin Oncol. 2013 Dec 20;31(36):4544-9
pubmed: 24248693
FEBS J. 2021 Dec;288(24):7073-7095
pubmed: 33448150
Semin Cell Dev Biol. 2012 Sep;23(7):785-93
pubmed: 22659496
Ann Cardiothorac Surg. 2012 Nov;1(4):491-6
pubmed: 23977542
J Exp Clin Cancer Res. 2019 Apr 12;38(1):158
pubmed: 30979377
Front Oncol. 2021 Nov 11;11:748444
pubmed: 34900693
Mol Pathol. 1999 Aug;52(4):189-96
pubmed: 10694938
Cancer Gene Ther. 2013 Aug;20(8):453-60
pubmed: 23928732
Nat Cell Biol. 2011 Aug 01;13(8):877-83
pubmed: 21808241
Cancers (Basel). 2021 Jan 16;13(2):
pubmed: 33467099
Dev Cell. 2010 Feb 16;18(2):300-8
pubmed: 20159599
EMBO Rep. 2016 Feb;17(2):188-201
pubmed: 26691213
Arch Pathol Lab Med. 2012 Mar;136(3):277-93
pubmed: 22372904
Immunity. 2013 Jul 25;39(1):1-10
pubmed: 23890059
Tumour Biol. 2012 Dec;33(6):2135-41
pubmed: 22886525
Genes Dev. 2012 Jun 15;26(12):1300-5
pubmed: 22677547
Oncogene. 2015 Jun 11;34(24):3095-106
pubmed: 25109332
J Thorac Oncol. 2015 Mar;10(3):492-9
pubmed: 25514803
J Pharm Sci. 2019 Oct;108(10):3218-3224
pubmed: 31229434
Cell Signal. 2016 Nov;28(11):1761-72
pubmed: 27519476
Int J Oncol. 2001 Feb;18(2):425-33
pubmed: 11172613
Cell Rep. 2017 Mar 7;18(10):2464-2479
pubmed: 28273460
J Cell Physiol. 2012 Jan;227(1):44-58
pubmed: 21412769
Future Oncol. 2017 Dec;13(28):2537-2546
pubmed: 29086616
J Transl Med. 2019 Apr 8;17(1):116
pubmed: 30961610
Oncogene. 2007 Feb 8;26(6):836-50
pubmed: 16953231
Front Cell Dev Biol. 2017 Mar 07;5:18
pubmed: 28326306
Oncol Rep. 2010 Aug;24(2):423-31
pubmed: 20596629
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 Sep-Oct;1(5):511-29
pubmed: 20049814
Nat Rev Cancer. 2007 Feb;7(2):147-54
pubmed: 17251920
Pathol Int. 2011 Jun;61(6):331-44
pubmed: 21615608
Dev Cell. 2010 Dec 14;19(6):831-44
pubmed: 21145499
Cancer Res. 2011 Feb 1;71(3):873-83
pubmed: 21245096
J Cell Biol. 2000 May 29;149(5):1073-86
pubmed: 10831611
J Cell Physiol. 2017 May;232(5):922-927
pubmed: 27739063
J Thorac Oncol. 2016 Oct;11(10):1615-26
pubmed: 27282309
Oncogene. 2006 Sep 28;25(44):5960-8
pubmed: 16652148
Cancer Sci. 2012 Mar;103(3):510-4
pubmed: 22146010
Nature. 2006 Sep 14;443(7108):210-3
pubmed: 16906135
Mol Cell. 2008 Feb 15;29(3):350-61
pubmed: 18280240
Cancer Lett. 2021 Jun 1;507:112-123
pubmed: 33737002
Dev Cell. 2019 May 20;49(4):590-604.e9
pubmed: 31080060
Mol Cell Proteomics. 2017 Jun;16(6):1098-1110
pubmed: 28373298
Science. 2004 Feb 13;303(5660):1010-4
pubmed: 14963330
Chest. 2002 Dec;122(6):2224-9
pubmed: 12475867
Genes Dev. 2001 Apr 15;15(8):968-80
pubmed: 11316791
J Biol Chem. 2005 May 27;280(21):20310-5
pubmed: 15784621
Cell Signal. 2011 Sep;23(9):1433-40
pubmed: 21539912
J Thorac Dis. 2018 Jan;10(Suppl 2):S237-S245
pubmed: 29507791
Annu Rev Biochem. 2019 Jun 20;88:577-604
pubmed: 30566373
J Toxicol Environ Health B Crit Rev. 2016;19(5-6):151-172
pubmed: 27705546
Genes Dev. 2016 Jan 1;30(1):1-17
pubmed: 26728553
Oncoimmunology. 2015 Mar 19;4(6):e1009285
pubmed: 26155428
FASEB J. 2020 Oct;34(10):13125-13139
pubmed: 32830349
Biochim Biophys Acta. 2014 Apr;1845(2):232-47
pubmed: 24491449
Carcinogenesis. 2009 Jul;30(7):1097-105
pubmed: 19380521
Cancer Biol Ther. 2013 Jun;14(6):511-20
pubmed: 23760493
Cancer Res. 1995 Mar 15;55(6):1227-31
pubmed: 7882313
Biochim Biophys Acta. 2013 Feb;1830(2):2323-34
pubmed: 22824335
PLoS One. 2013 Apr 16;8(4):e61916
pubmed: 23613971
Front Oncol. 2020 Feb 18;10:126
pubmed: 32133285
J Biol Chem. 2011 Mar 4;286(9):7018-26
pubmed: 21224387
Sci Signal. 2011 May 24;4(174):ra33
pubmed: 21610251
J Am Acad Dermatol. 2014 Nov;71(5):888-95
pubmed: 25064638
FEBS Lett. 2003 Jul 3;546(1):73-80
pubmed: 12829239
Proc Natl Acad Sci U S A. 2011 Aug 16;108(33):13618-23
pubmed: 21788493
J Thorac Dis. 2021 Mar;13(3):1851-1863
pubmed: 33841973
Cancer Lett. 2007 Jul 18;252(2):225-34
pubmed: 17276588
Cell Death Differ. 2015 Jul;22(7):1181-91
pubmed: 25571977
Dis Markers. 2017;2017:1310478
pubmed: 29085180
Cancer Res. 2016 Mar 15;76(6):1627-40
pubmed: 26759237
Bioessays. 2016 Jul;38(7):644-53
pubmed: 27173018
Gene. 1995 Dec 29;167(1-2):303-6
pubmed: 8566796
Transl Lung Cancer Res. 2020 Feb;9(Suppl 1):S39-S46
pubmed: 32206569
Expert Rev Respir Med. 2015 Oct;9(5):633-54
pubmed: 26308799
J Clin Oncol. 2018 Oct 1;36(28):2863-2871
pubmed: 30113886
Int J Mol Med. 2020 Jun;45(6):1783-1792
pubmed: 32236608
Cancer Res. 2020 Jul 15;80(14):3046-3056
pubmed: 32354737